MLM Medical Labs launches a new E-Requisition solution designed to improve data quality, reduce sample-related queries, and support faster clinical trial timelines.
Cytespace Africa Laboratories, an MLM company, has launched in-region Next-Generation Sequencing (NGS) capabilities to eliminate delays in African clinical trials. The new platform enables faster, more precise genomic insights—particularly for infectious diseases like tuberculosis—by delivering critical resistance and safety data directly within Africa.
MLM Medical Labs’ IVDR-validated LDT for the pTau217/β-amyloid ratio is now in active use in a European clinical trial, supporting biomarker-driven patient selection.
Cytespace Africa Laboratories, an MLM Company, announces a major infrastructure expansion in South Africa. By localizing kit building and specimen management, Cytespace is reducing logistics complexity and costs for global sponsors expanding into the growing Sub-Saharan African clinical trials market.
Cytespace Africa Laboratories, a CAP-accredited MLM Medical Labs company, has tripled its molecular testing capacity to support faster, high-throughput clinical trials across Sub-Saharan Africa.
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce the expansion of its laboratory facilities in Mönchengladbach to support its growing operations. The new start-of-the-art facilities will become the dedicated home for MLM’s global logistics department and for MLM Kit Building®, an industry leading clinical trials kit building operation.
MLM Medical Labs Acquires Cytespace Africa Laboratories Read More »
MLM Medical Labs Approved by French Ministry for R&D and Innovation Tax Incentives Decision strengthens MLM’s standing as a proven and preferred partner in European life sciences MÖNCHENGLADBACH, GERMANY – April 10, 2025 MLM Medical Labs (MLM), a global leader in specialty and central laboratory services, is proud to announce that it has received dual
MLM Medical Labs Approved by French Ministry for R&D and Innovation Tax Incentives Read More »
MLM Medical Labs – Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence MÖNCHENGLADBACH, GERMANY – March 11, 2025 MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, announced today it has received notice of continued accreditation from the College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce the expansion of its laboratory facilities in Mönchengladbach to support its growing operations. The new start-of-the-art facilities will become the dedicated home for MLM’s global logistics department and for MLM Kit Building®, an industry leading clinical trials kit building operation.
MLM Medical Labs Announces Collaboration with Cytespace Read More »
MLM Medical Labs (MLM), a global leader in central and specialty laboratory services, is pleased to announce the expansion of its laboratory facilities in Mönchengladbach to support its growing operations. The new start-of-the-art facilities will become the dedicated home for MLM’s global logistics department and for MLM Kit Building®, an industry leading clinical trials kit building operation.
MLM Medical Labs Poised for Growth with Facilities Expansion in Mönchengladbach Read More »
